loading page

Titel: Reported physical symptoms during screening echocardiography is not associated with the presence of suspected hypertrophic cardiomyopathy.
  • Mohammad Reza Movahed,
  • Ashkan Bahrami,
  • Sharon Bates
Mohammad Reza Movahed
The University of Arizona Sarver Heart Center

Corresponding Author:rmova@aol.com

Author Profile
Ashkan Bahrami
The University of Arizona Sarver Heart Center
Author Profile
Sharon Bates
Anthony Bates Foundation
Author Profile

Abstract

Background: The prevalence of hypertrophic cardiomyopathy (HCM) can be silent and can present with sudden death as the first manifestation of this disease. The goal of this study was to evaluate any association between reported physical symptoms with the presence of suspected HCM. Method: The Anthony Bates Foundation has been performing screening echocardiography across the United States for the prevention of sudden death since 2001. A total of 4,120 subjects between the ages of 6 and 79 underwent echocardiographic screening. We evaluated any association between any symptoms and suspected HCM defined as any left ventricular wall thickness ≥ 15 mm. Results: The total prevalence of suspected HCM in the entire study population was 1.1%. The presence of physical symptoms were not associated with HCM (chest pain in 4.3% of participant with HCM vs. 9.9% of the control, p=0.19, palpitation in 4.3% of participant with HCM vs. 7.3% of the control., p=0.41, shortness of breath in 6.4% of participant with HCM vs. 11.7% of the control., p=0.26, lightheadedness in 4.3% of participant with HCM vs. 13.1% of the control., p=0.07, ankle swelling in 2.1% of participant with HCM vs. 4.0% of the control., p=0.52, dizziness in 8.5% of participant with HCM vs. 12.2% of the control., p=0.44). Conclusion: Echocardiographic presence of suspected HCM is not associated with a higher prevalence of physical symptoms in the participants undergoing screening echocardiography. This finding confirmed that HCM can be asymptomatic in many patients and a questionnaire cannot distinguish the HCM population from a control group.
04 Nov 2023Submitted to Echocardiography
04 Nov 2023Submission Checks Completed
04 Nov 2023Assigned to Editor
06 Nov 2023Reviewer(s) Assigned